Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Azvudine therapy of common COVID‐19 in hemodialysis patients
Shunlai Shang, Bo Fu, Yanqiu Geng, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 13

Showing 13 citing articles:

Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis
Yaqi Wang, Huaiya Xie, Luo Wang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
Benchen Rao, Daming Wang, Mengzhao Yang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Behnam Amani, Bahman Amani
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial
Yiling Zhou, Yi Liu, Li Jiang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 7
Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study
Abiden Kapar, Songsong Xie, Zihao Guo, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 569-577
Closed Access | Times Cited: 1
Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis
Bahman Amani, Behnam Amani
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0298772-e0298772
Open Access | Times Cited: 1
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
Nan Shang, Xianlin Li, Zhiyu Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Allograft function predicts mortality in kidney transplant recipients with severe COVID-19: a paradoxical risk factor
Han Luo, Jingyu Wen, Hongji Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Azvudine alleviates SARS-CoV-2-induced inflammation by targeting myeloperoxidase in NETosis
Li Yang, Ning Sheng, Kun Wang, et al.
Chinese Chemical Letters (2024), pp. 110238-110238
Closed Access
Efficacy and Safety of Azvudine in Patients With COVID‐19 in China: A Meta‐Analysis of Observational Studies
Tao Dong, Wentao Zhang, Tingting Wu, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 7
Open Access
Efficacy of Azvudine Therapy in Patients with Severe and Non-Severe COVID‐19: A Propensity Score-Matched Analysis
S H Zhang, Songsong Tan, Bin Yang, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 4317-4325
Open Access
Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study
Yuanchao Zhu, Fei Zhao, Yubing Zhu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 123-132
Open Access
Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China
Wenfang Yuan, Yongmei Liu, Haoting Zhan, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Page 1

Scroll to top